Mississauga, ON -- (SBWIRE) -- 06/25/2014 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “Miraculins Moves One Step Closer to Meaningful Revenue with Scout DS Launch in China.”
ompanies mentioned in this article include Foundation Medicine (NASDAQ:FMI) and Miraculins Inc. (TSX-Venture:MOM).
The world needs new, reliable diagnostic tests for a host of indications and at a variety of levels to help manage costs and deliver better patient outcomes. A high degree of variance in unmet needs for different diseases from country to country presents a broad set of challenges, but there are some exciting developments in the diagnostics space that can provide some solutions. For instance, in developed nations, liver tests to monitor the side effects of HIV and tuberculosis drugs are readily available and covered by payers, but in many emerging countries, those where the two indications remain leading killers, simple diagnostics and equipment are limited, to say the least. However, researchers at Diagnostics for All are developing a simple test that uses only a drop of blood to evaluate any possible liver damage that only costs about 10 cents a piece and gives results of the test in 15 minutes. In the U.S., diagnostic companies, such as Foundation Medicine (NASDAQ:FMI) have introduced tumor sample tests that can scan biopsies for more than 200 cancer-related genes to try and delineate what’s driving tumor growth, but the FDA still hasn’t approved it and Medicare still fights the company to receive reimbursement, again, highlighting unique problems in the system to provide the best medical care.
Winnipeg, Manitoba-based Miraculins Inc. (TSX-Venture:MOM), a diagnostics company focused on non-invasive technologies for unmet medical needs, is rolling-out tests for diabetes, coronary artery disease and preeclampsia, a complication of pregnancy characterized by high blood pressure and often kidney damage.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.